These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 94385)

  • 1. Comparison between the acute hemodynamic effects and brain penetration of atenolol and metoprolol.
    van Zwieten PA; Timmermans PB
    J Cardiovasc Pharmacol; 1979; 1(1):85-96. PubMed ID: 94385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain levels and acute antihypertensive activity of beta-blockers.
    van Zwieten PA; Timmermans PB
    Eur J Clin Pharmacol; 1985; 28 Suppl():13-9. PubMed ID: 2865143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-adrenoceptor blockade by atenolol, metoprolol and propranolol in the anaesthetized cat.
    Lundgren B; Carlsson E; Herrmann I
    Eur J Pharmacol; 1979 May; 55(3):263-8. PubMed ID: 37096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative activities of atenolol and metoprolol on the cardiovascular system of man.
    Harry JD; Cruickshank JM; Young J; Barker N
    Eur J Clin Pharmacol; 1981; 20(1):9-15. PubMed ID: 7308277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor occupancy in lumbar CSF as a measure of the antagonist activity of atenolol, metoprolol and propranolol in the CNS.
    Kaila T; Marttila R
    Br J Clin Pharmacol; 1993 May; 35(5):507-15. PubMed ID: 8099803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of 100 mg of controlled-release metoprolol and 100 mg of atenolol on blood pressure, central nervous system-related symptoms, and general well being.
    Walle PO; Westergren G; Dimenäs E; Olofsson B; Albrektsen T
    J Clin Pharmacol; 1994 Jul; 34(7):742-7. PubMed ID: 7929868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. beta-Adrenoreceptor-blocking agents and the blood-brain barrier.
    Cruickshank JM; Neil-Dwyer G; Cameron MM; McAinsh J
    Clin Sci (Lond); 1980 Dec; 59 Suppl 6():453s-455s. PubMed ID: 7449299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metoprolol, but not atenolol, reduces stress induced neuropeptide Y release in pigs.
    Åblad B; Bjurö T; Björkman JA; Brax O; Ewaldsson L; Forshult E; Lidfors L; Lundberg JM
    Scand Cardiovasc J; 2010 Oct; 44(5):273-8. PubMed ID: 21080845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atenolol and metoprolol: comparison of effects on blood pressure and serum lipoproteins, and side effects.
    Rössner S; Weiner L
    Eur J Clin Pharmacol; 1983; 24(5):573-7. PubMed ID: 6873132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of metoprolol, propranolol and atenolol with concurrent administration of cimetidine.
    Kirch W; Spahn H; Köhler H; Ohnhaus EE; Mutschler E
    Klin Wochenschr; 1982 Nov; 60(22):1401-7. PubMed ID: 7176462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The comparative beta-adrenoceptor blocking effects of penbutolol, atenolol and sustained-release metoprolol in healthy volunteers.
    Mucklow JC; Kuhn S
    Eur J Clin Pharmacol; 1984; 27(3):269-73. PubMed ID: 6510453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of atenolol, metoprolol, and propranolol on isoproterenol-induced tremor and tachycardia in normal subjects.
    Perucca E; Pickles H; Richens A
    Clin Pharmacol Ther; 1981 Apr; 29(4):425-33. PubMed ID: 6258838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central nervous system kinetics of atenolol and metoprolol in the dog during long term treatment.
    Abrahamsson T; Lignell E; Mikulski A; Olovson SG; Regårdh CG
    Drug Metab Dispos; 1989; 17(1):82-6. PubMed ID: 2566475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is metoprolol CR/ZOK more selective than conventional metoprolol and atenolol?
    Kendall M; Akhlaghi S; Hughes B; Lewis H
    J Clin Pharmacol; 1990 Feb; 30(S2):S98-102. PubMed ID: 2155948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relative activities of atenolol and metoprolol on the cardiovascular system of man [proceedings].
    Harry JD; Cruikshank JM; Young JM
    Br J Clin Pharmacol; 1980 Mar; 9(3):296P-297P. PubMed ID: 7362752
    [No Abstract]   [Full Text] [Related]  

  • 16. Central cardiovascular effects of physostigmine in the cat; possible cholinergic aspects of blood pressure regulation.
    de Wildt DJ; Porsius AJ
    Arch Int Pharmacodyn Ther; 1981 Sep; 253(1):22-39. PubMed ID: 6119963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.
    Floras JS; Jones JV; Hassan MO; Sleight P
    Br Med J (Clin Res Ed); 1982 Nov; 285(6352):1387-92. PubMed ID: 6814568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects on exercise tachycardia during forty-eight hours of a series of doses of atenolol, sotalol, and metoprolol.
    Harron DW; Balnave K; Kinney CD; Wilson R; Russell CJ; Shanks RG
    Clin Pharmacol Ther; 1981 Mar; 29(3):295-302. PubMed ID: 7471600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of beta-adrenoceptor blockers under maximal exercise (pindolol v metoprolol v atenolol).
    Erikssen J; Thaulow E; Mundal R; Opstad P; Nitter-Hauge S
    Br J Clin Pharmacol; 1982; 13(Suppl 2):201S-209S. PubMed ID: 6125171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of metoprolol and atenolol to neuropeptide Y blockade in coronary artery disease.
    Gullestad L; Pernow J; Bjurö T; Aaberge L; Skårdal R; Kjekshus E; Høglund L; Mellgård AJ; Wahlquist I; Ablad B
    Scand Cardiovasc J; 2012 Feb; 46(1):23-31. PubMed ID: 22017530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.